Metastatic colorectal cancer (mCRC) continues to pose a clinical and commercial challenge, with low 5-year survival rates and limited durable responses to existing therapies. While standard ...

“It is crucial to be intentional when discussing a cancer diagnosis with loved ones,” Perkins said. “I’ve seen how Ackerman ...

Learn how single-cell transcriptomics is helping researchers explore gene activity and immune system diseases with ...

A new study estimates that 19 million children in the U.S. have a parent with a substance use disorder and that alcohol is ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

First of several clinical updates through mid-2026 accepted for presentation at the 2025 American Society of Clinical Oncology Annual Meeting, with recruitment progressing for all three of our ...

Each student in the Undergraduate Research Scholars Program worked with a faculty mentor throughout the academic year, developing a proposal, conducting research and presenting their findings through ...

Welcome to the Legend Biotech’s First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer ...

Reported Net Product Revenues of $20.9 million for the first quarter of 2025, a year-over-year increase of approximately 8% National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines ...

First of several clinical updates through mid-2026 accepted for presentation at the 2025 American Society of Clinical Oncology Annual Meeting, with recruitment progressing for all three of our clinica ...

Cash: As of March 31, 2025, Cellectis had $246 million in consolidated cash, cash equivalents, restricted cash and fixed-term deposits classified as current-financial assets. The Company believes its ...

As of March 31, 2025, Tonix had $131.7 million of cash and cash equivalents, compared to $98.8 million as of December 31, 2024. Net cash used in operations was approximately $16.6 million for first ...